LO ANDREW received a stock award from BRIDGEBIO PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/24/2026ACC: 0001470831-26-000634
+9.27K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
9.27K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.99K
Price / share
—
Trade value
—
% of position
28.3%
6/22/2026
14.09K→18.08K
Total
Net shares
+3.99K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | A · Award | +3.99K | — | — | 28.3% | 14.09K | 18.08K |
| Total | +3.99K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.28K shares
Shares
+5.28K
Strike price
68.92
Held after
5.28K
Exercisable
—
6/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.28K shares | 6/22/2026 | A · Award | +5.28K | 68.92 | — | 5.28K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned50.58K
Total
50.58K indirect50.58K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 50.58K | Indirect |
| Total | 50.58K | 50.58K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported